Insulin-like growth factor-1 stimulation of lymphopoiesis

Journal of Clinical Investigation

Volumn 92, Issue 2, 1993, Pages 540-548

  Clark, Ross ^a   Stresser, Josef ^a   McCabe, Susan ^a   Bobbins, Kimberly ^a   Jardieu, Paula ^a  

^a GENENTECH INC   (United States)

Author keywords

B cells; CD4+ T cells; Immunoglobulin G; Lymphopoiesis; Recombinant human insulin like growth factor 1

Indexed keywords

ALLOANTIGEN; ANABOLIC AGENT; CD4 ANTIGEN; CHOLESTEROL; CONCANAVALIN A; CREATININE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLOBULIN; GLUCOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; OVALBUMIN; POKEWEED MITOGEN; PROTEIN; RECOMBINANT SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CHEMISTRY; BODY WEIGHT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOPOIESIS; MALE; MITOGENESIS; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SPLEEN WEIGHT; SUBCUTANEOUS DRUG ADMINISTRATION; THYMUS; UREA NITROGEN BLOOD LEVEL;

ANIMAL; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN G; INFUSIONS, PARENTERAL; INSULIN-LIKE GROWTH FACTOR I; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MITOGENS; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMUS GLAND; TIME FACTORS;

EID: 0027202753     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116621     Document Type: Article

References (38)

1. Froesch, E. R., H. P. Guler, M. Ernst, C. Schmid, E. Scheiwiller, and J. Zapf. 1987. Growth promoting and hypoglycemic effects of human recombinant IGF-1 in vivo in the context of in vitro actions of IGF-1. In Growth Hormone Basic and Clinical Aspects. O. Isaksson, C. Binder, K. Hall, and B. Hokfelt, editors. Elsevier, Amsterdam. 321-336.
2. Guler, H. P., J. Zapf, E. Scheiwiller, and R. Froesch. 1988. Recombinant human insulin-like growth factor-1 stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl. Acad. Sci. USA. 85:4889-4893.
3. Skottner, A., R. G. Clark, L. Frykliund, and I. Robinson. 1989. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor-1. Endocrinology. 124:2519-2526.
4. Binz, K., P. Joller, P. Froesch, H. Binz, J. Zapf, and E. R. Froesch. 1990. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor-1. Proc. Natl Acad. Sci. USA. 87:3690-3694.
5. Kelley, K. 1990. The role of growth hormone in modulation of the immune response. Ann. N. Y. Acad. Sci. 594:95-118.
6. Ammann, A. 1988. Growth hormone and immunity. In Human Growth Hormone-Progress and Challenges. L. Underwood, editor. Marcel Dekker, Inc., New York. 243-253.
7. Weigent, D. A., and J. E. Blalock. 1990. Growth hormone and the immune system. Prog. Neuroendocrinimmunol. 3:231-241.
8. Fabris, N., W. Pierpaoli, and E. Sorkin. 1971. Hormones and immunological capacity. III. The immunodeficiency disease of the hypopituitary Snell-Bragg dwarf mouse. Clin. Exp. Immunol. 9:209-225.
9. Murphy, W. J., S. K. Durum, and D. L. Longo. 1992. Human growth hormone promotes engraftment of murine and human T cell in severe combined immunodeficient mice. Proc. Natl. Acad. Sci. USA. 89:4481-4485.
10. Timsit, J., W. Savino, B. Safieh, P. Chanson, M. C. Gagnerault, J. F. Bach, and M. Dardenne. 1992. Growth hormone and insulin-like growth factor-1 stimulate hormonal function and proliferation of thymic epithelial cells. J. Clin. Endocrinol. Metab. 75:183-188.
11. Kelley, K. W. 1989. Growth hormone, lymphocytes and macrophages. Biochem. Pharmacol. 38:705-713.
12. Khansari, D. N., and T. Gustad. 1991. Effects of long-term, low-dose growth hormone therapy on immune function and life expectancy of mice. Mech. Aging Dev. 57:87-100.
13. Geffner, M. E., N. Bersch, B. M. Lippe, R. G. Rosenfeld, R. L. Hintz, and D. W. Golde. 1990. Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-1. J. Clin. Endocrinol. Metab. 71:464-469.
14. Tapson, V. F., M. Boni Schnetzler, P. F. Pilch, D. M. Center, and J. S. Berman. 1988. Structural and functional characterization of the human T-lymphocyte receptor for insulin-like growth factor-1 in vitro. J. Clin. Invest. 82:950-957.
15. Stuart, C. A., R. T. Meehan, L. S. Neale, N. M. Cintron, and R. W. Furlanetto. 1991. Insulin-like growth factor-1 binds selectively to human peripheral blood monocytes and B-lymphocytes. J. Clin. Endocrinol. Metab. 72:1117-1122.
16. Schimpff, R. M., A. M. Repellin, A. Salvatoni, G. Thieriot-Prevost, and P. Chatelian. 1983. Effect of purified somatomedins on thymidine incorporation into lectin-activated human lymphocytes. Acta. Endocrinol. 102:21-26.
17. Merchav, S., I. Tatarsky, and Z. Hochberg. 1988. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor-1/somatomedin C and human growth hormone. J. Clin. Invest. 81:791-795.
18. Beschorner, W. E., J. Divic, H. Pulido, X. Yao, P. Kenworthy, and G. Bruce. 1991. Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor-1. Transplantation. 52:879-884.
19. Ranges, G. E., M. Bombara, R. Aiyer, G. Rice, and M. Palladino. 1989. Tumor necrosis factor-α as a proliferative signal for IL-2 dependent T cell line: strict species specificity. J. Immunol. 142:1203-8.
20. Daughaday, W. H., K. Hall, M. S. Raben, W. D. Salmon, J. L. Van den Brande, and J. J. Van Wyk. 1972. Somatomedin: proposed designation for sulphation factor. Nature (Lond.). 235:107.
21. Daughaday, W. H., K. Hall, M. S. Raben, W. D. Salmon, J. L. Van den Brande, and J. J. Van Wyk. 1987. On the nomenclature of the somatomedins and insulin-like growth factors. J. Clin. Endocrinol. Metab. 65:1075-1076.
22. Holder, A. T., E. M. Spencer, and M. A. Preece. 1981. Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters. J. Endocrinol. 89:275-282.
23. Van Buul-Offers, S., I. Ujeda, and J. L. Van den Brande. 1986. Biosynthetic somatomedin C (SMC/IGF-1) increases the length and weight of Snell dwarf mice. Pediatr. Res. 20:825-827.
24. Woodall, S. M., B. H. Breier, U. O'Sullivan, and P. D. Gluckman. 1991. The effect of frequency of subcutaneous insulin-like growth factor-1 administration on weight gain in growth hormone deficient mice. Harm. Metab. Res. 23:581-584.
25. Ballard, F. J., F. M. Tomas, L. C. Read, S. E. Knowles, P. C. Owens, A. B. Lemmey, A. A. Martin, J. R. E. Wells, J. C. Wallace, and G. L. Francis. 1991. Effects of IGF-1 and IGF analogs on growth during catabolic states in rats. In Modern concepts of insulin-like growth factors. E. M. Spencer, editor. Elsevier, Amsterdam. 617-627.
26. Groesbeck, M. D., A. F. Parlow, and W. H. Daughaday. 1987. Stimulation of supranormal growth in prepubertal, adult plateaued, and hypophysectomized female rats by large doses of rat growth hormone: physiological effects and adverse consequences. Endocrinology. 120:1963-1975.
27. Schuurman, H., P. Brekelmans, T. Dacmen, R. Broekhuizen, and L. Kates. 1983. T cell maturation in the human thymus and tonsil: peanut agglutinin binding T lymphocytes in thymus and tonsil differ in maturation stage. Clin. Immunol. Immunopathol. 29:271-81.
28. Dzlanski, R. 1985. Ontogenic development of proliferation and polyclonal antibody responses to staphylococal peptidoglycan, protein A and cell walls in mice. Dev. Comp. Immunol. 9:119-30.
29. Landreth, K. S., R. Narayanan, and K. Dorshkind. 1992. Insulin-like growth factor-1 regulates Pro-B-ceII differentiation. Blood. 80:1-6.
30. Rodriguez-Tarduchy, G., M. Collins, I. García, and A. López-Rivas. 1992. Insulin like growth factor-1 inhibits apoptosis in IL-3 dependent hemopoetic cells. J. Immunol. 149:535-40.
31. Zurzrock, R., Z. Estrov, M. Talpaz, and J. U. Guterman. 1991. Cytokines in tumor therapy. Am. J. Clin Oncol. 14:45-50.
32. Atkinson, K., C. Matias, A. Guiffre, R. Seymour, M. Cooley, J. Biggs, V. Munro, and S. Gillis. 1991. In vivo administration of G-CSF, GM-CSF, Interleukin-1 (IL-1) and IL-4 alone and in combination after allogeneic murine hematopoietic stem cell transplantation. Blood. 77:1376-82.
33. Charak, B. S., G. D. Choushaary, M. Tefft, and A. Mazzuramder. 1992. Interleukin-2 in bone marrow transplantation preclinical studies. Bone Marrow Transplant. 10:103-11.
34. Leshem, B., R. Dekel, H. Bercovier, R.Tchakirov, I. Polacheck, Z. ZakayRomes, M. Scheesinger, and E. Kedar. 1992. Cytokine induced resistance to microbial infections in normal, immunosuppressed and bone marrow transplanted mice. Bone Marrow Transplant. 9:471-7.
35. Mackensen, A., C. Galanos, and R. Engelhardt. 1991. Treatment of cancer patients with endotoxin induces release of endogenous cytokines. Pathobiology. 59:264-7.
36. Murphy, W., S. Durum, and D. Longo. 1992. Role of neuroendocrine hormones in murine T-cell development. J. Immunol. 149:3851-57.
37. Underwood, L. E., J. P. Thissen, B. M. Moats-Staats, E. Bruton, M. Maes, and J. M. Ketelslegers. 1991. Nutritional regulation of IGF-1 and postnatal growth. In Modern Concepts of Insulin-like Growth Factors. E. M. Spencer, editor. Elsevier, Amsterdam. 37-47.
38. Ham, A. W. 1965. The Thymus. In Histology 5th edition. J. P. Lippincott Co., Philadelphia. 338-348.